Medical News

RSS

UW named a final winner in Head Health Challenge II

Today, the University of Washington was named a final winner in the Head Health Challenge II, a collaboration among the NFL, Under Armour, and GE to identify and fund innovations that improve head health for athletes, members of the military and society at-large.

9 Dec 2015

UHCO's Pat Segu earns prestigious distinguished service award in vision care

The University of Houston College of Optometry's Pat Segu, O.D., was honored with a prestigious distinguished service award for the continued high quality of service she has demonstrated in the area of public health eye and vision care.

9 Dec 2015

RTFCCR grant supports ASCOLT study that evaluates effectiveness of Aspirin in colorectal cancer patients

Rising Tide Foundation for Clinical Cancer Research, an international private foundation based in Switzerland, has awarded a US $800,000 grant to be released over two years for the ASCOLT study conducted by Dr John Chia, Senior Consultant Medical Oncologist at the Division of Medical Oncology, National Cancer Centre Singapore.

9 Dec 2015

New drug therapies that target glutamate pathway may be effective for subgroups of patient with schizophrenia

Mounting evidence indicates that disturbances in the brain's glutamate pathway contribute to symptoms of schizophrenia. Thus, the glutamate pathway has become the target of a number of new drug therapies. Findings published in the journal Biological Psychiatry suggest that at least one of these drugs may be an effective treatment for individuals in the early course of the illness.

9 Dec 2015

Brief dissonance-based eating disorder prevention program alters how brains respond to supermodels

Scientists at Oregon Research Institute have published unique research results indicating that a brief dissonance-based eating disorder prevention program (Body Project) alters how young women's brains respond to images of thin supermodels.

9 Dec 2015

Treatment with antiplatelet therapy does not reduce pain crises in children with sickle cell disease

Treatment with the antiplatelet agent prasugrel does not significantly reduce the rate of pain crises or severe lung complications in children with sickle cell disease, according to a report published in the New England Journal of Medicine describing one of the largest and most geographically diverse international clinical trials on sickle cell disease to date.

9 Dec 2015

Lawson scientists develop commercial imaging product for PET/MRI scanners

Scientists at Lawson Health Research Institute, in collaboration with Ceresensa Inc., have produced the first commercial imaging product available in the world for PET/MRI scanners. The novel PET-transparent MRI head coil provides unparalleled images to advance the study, diagnosis and treatment of a wide range of diseases.

9 Dec 2015

Novel antidepressant appears to be safe, effective against depression in clinical trial

A small clinical trial of a novel antidepressant that stimulates neurogenesis - the production of new brain cells - shows that the compound appears to be safe and may be effective against depression.

9 Dec 2015

Harvard's Kevin Staley honored with AES Research Recognition Award for Basic Science

The American Epilepsy Society announces that Kevin Staley, M.D., professor of child neurology and mental retardation at Harvard Medical School and chief of pediatric neurology at Massachusetts General Hospital, is being honored with the AES Research Recognition Award for Basic Science at the Society's 69th annual meeting in Philadelphia.

8 Dec 2015

Barry University to be awarded Florida Blue Foundation grant for Statewide Nursing Leadership Development program

Barry University will receive a $225,000 grant from the Florida Blue Foundation to create and implement a two-year Statewide Nursing Leadership Development program. Over the grant period, a cohort of 32 nurse professionals from eight regions of Florida – East Central, Northeast, Northwest, North Central, Southeast, Southwest, South and West Central - will receive additional education about health policy and leadership in health care systems with a goal of enabling them to become more influential in the field.

8 Dec 2015

Flavoring chemicals in e-cigarettes linked to severe respiratory disease

Diacetyl, a flavoring chemical linked to cases of severe respiratory disease, was found in more than 75% of flavored electronic cigarettes and refill liquids tested by researchers at Harvard T.H. Chan School of Public Health.

8 Dec 2015

Easy and fast way to bring relief to nauseated patients in emergency department

Nauseated patients in the emergency department who sniffed pads saturated with isopropyl alcohol were twice as likely to obtain relief from their symptoms as nauseated patients who sniffed pads saturated with saline solution, according to a study published online today in Annals of Emergency Medicine ("Isopropyl Alcohol Nasal Inhalation for Nausea in the Emergency Department: A Randomized Controlled Trial").

8 Dec 2015

FDA approves recombinant von Willebrand factor for treating bleeding episodes in adults with VWD

The U.S. Food and Drug Administration today approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD). Vonvendi is the first FDA-approved recombinant von Willebrand factor, and is approved for the on-demand (as needed) treatment and control of bleeding episodes in adults diagnosed with VWD.

8 Dec 2015

Roche announces regulatory clearance to finalize acquisition of Kapa Biosystems

Roche today announced regulatory clearance to finalize acquisition of Kapa Biosystems, Inc., a privately-held company headquartered in Wilmington, Massachusetts, US.

8 Dec 2015

Oxitec prepares to increase supplies of OX513A to address recent outbreak of Zika virus in Brazil

Intrexon Corporation, a leader in synthetic biology, today announced that Oxitec, a UK-based subsidiary of the Company, is prepared to increase supplies of its proprietary mosquito control solution, OX513A, through its Brazil facilities to assist Brazil in addressing the recent devastating outbreak of the Zika virus and other diseases transmitted by the Aedes aegypti mosquito.

8 Dec 2015

Kewaunee Scientific's sales increase 2.6% to $31 million in second quarter 2015

Kewaunee Scientific Corporation today reported results for its second quarter ended October 31, 2015.

8 Dec 2015

Bionomics plans to launch BNC210 Phase 2 trial for treatment of PTSD

Australian drug development company Bionomics Limited will launch a key Phase 2 trial of its novel anxiety drug BNC210 as a treatment for post-traumatic stress disorder (PTSD), following a US$12 million private placement to US institutional investors.

8 Dec 2015

Kanuma approved as first treatment for patients with LAL deficiency

Today, the U.S. Food and Drug Administration approved Kanuma (sebelipase alfa) as the first treatment for patients with a rare disease known as lysosomal acid lipase (LAL) deficiency.

8 Dec 2015

Penn's Brian Litt recognized with AES Research Recognition Award for Clinical Science

The American Epilepsy Society announces that Brian Litt, M.D., professor of neurology, neurosurgery and bioengineering at the University of Pennsylvania, is being honored with the AES Research Recognition Award for Clinical Science on December 7, 2015, at the Society's 69th annual meeting in Philadelphia.

8 Dec 2015

Researchers find links between Facebook connections and alcohol use among college-aged females

Researchers at the University of Georgia have found links between certain patterns of connections among Facebook friends and drug and alcohol use among college-aged females.

8 Dec 2015

Medical News

UW named a final winner in Head Health Challenge II

UHCO's Pat Segu earns prestigious distinguished service award in vision care

RTFCCR grant supports ASCOLT study that evaluates effectiveness of Aspirin in colorectal cancer patients

New drug therapies that target glutamate pathway may be effective for subgroups of patient with schizophrenia

Brief dissonance-based eating disorder prevention program alters how brains respond to supermodels

Treatment with antiplatelet therapy does not reduce pain crises in children with sickle cell disease

Lawson scientists develop commercial imaging product for PET/MRI scanners

Novel antidepressant appears to be safe, effective against depression in clinical trial

Harvard's Kevin Staley honored with AES Research Recognition Award for Basic Science

Barry University to be awarded Florida Blue Foundation grant for Statewide Nursing Leadership Development program

Flavoring chemicals in e-cigarettes linked to severe respiratory disease

Easy and fast way to bring relief to nauseated patients in emergency department

FDA approves recombinant von Willebrand factor for treating bleeding episodes in adults with VWD

Roche announces regulatory clearance to finalize acquisition of Kapa Biosystems

Oxitec prepares to increase supplies of OX513A to address recent outbreak of Zika virus in Brazil

Kewaunee Scientific's sales increase 2.6% to $31 million in second quarter 2015

Bionomics plans to launch BNC210 Phase 2 trial for treatment of PTSD

Kanuma approved as first treatment for patients with LAL deficiency

Penn's Brian Litt recognized with AES Research Recognition Award for Clinical Science

Researchers find links between Facebook connections and alcohol use among college-aged females

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News